Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer
World Journal of Oncology · 2026-06 · 17 (3) · 347-356
DOI: 10.14740/wjon2727 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2026-06. Verfasst von Chao Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China.
- Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China.
Zitieren
APA
Wu, C., & Yang, J. (2026). Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. World Journal of Oncology, 17(3), 347-356. https://doi.org/10.14740/wjon2727
Vancouver
Wu C, Yang J. Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. World Journal of Oncology. 2026;17(3):347-356. doi:10.14740/wjon2727
BibTeX
@article{Wu2026,
author = {Wu, Chao and Yang, Jun},
title = {Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer},
journal = {World Journal of Oncology},
year = {2026},
volume = {17},
number = {3},
pages = {347--356},
doi = {10.14740/wjon2727}
}
EUVIMED